The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Is NO an endogenous antiatherogenic molecule?
Open accessAbstract
E ndothelium-derived relaxing factor is now known to be nitric oxide (NO) or NO bound to a carrier molecule, possibly in the form of a nitrosothiol or nitrosoheme.13 NO is derived from the metabolism of L-arginine by NO synthase, which is expressed by a number of cell types, including endothelial cells, neurons, macrophages, platelets, and vascular smooth muscle cells.4
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
Palmer, R. M. J., Ferrige, A. G., & Moncada, S. (1987) · Nature · doi:10.1038/327524a0 · Cited by 10,704
Beckman, J. S., Beckman, T. W., Chen, J., Marshall, P. A., & Freeman, B. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.4.1620 · Cited by 7,029
The L-Arginine-Nitric Oxide Pathway
Epstein, F. H., Moncada, S., & Higgs, A. (1993) · New England Journal of Medicine · doi:10.1056/nejm199312303292706 · Cited by 6,678 · cited 1×
“NO is derived from the metabolism of L-arginine by NO synthase, which is expressed by a number of cell types, including endothelial cells, neurons, macrophages, platelets, and vascular smooth muscle cells.(4)”
BackgroundClancy, R. M., Leszczynska-Piziak, J., & Abramson, S. B. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115929 · Cited by 686
Cited by
De Caterina, R., Libby, P., Peng, H. B., Thannickal, V. J., Rajavashisth, T. B., Gimbrone, M. A., Shin, W. S., & Liao, J. K. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118074 · Cited by 1,782
The role of oxidized lipoproteins in atherogenesis
Berliner, J. A., & Heinecke, J. W. (1996) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(95)02173-6 · Cited by 1,366
Pathophysiology of Atherosclerosis
Jebari-Benslaiman, S., Galicia-García, U., Larrea-Sebal, A., Olaetxea, J. R., Alloza, I., Vandenbroeck, K., Benito-Vicente, A., & Martín, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063346 · Cited by 1,010
Endogenous Nitric Oxide Synthase Inhibitor: A Novel Marker of Atherosclerosis
Miyazaki, H., Matsuoka, H., Cooke, J. P., Usui, M., Ueda, S., Okuda, S., & Imaizumi, T. (1999) · Circulation · doi:10.1161/01.cir.99.9.1141 · Cited by 756
Self-citationEndothelial Dysfunction: Does It Matter? Is It Reversible?
Celermajer, D. S. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00189-7 · Cited by 681
Flow-Mediated Dilation and Cardiovascular Event Prediction: Does Nitric Oxide Matter?
Green, D. J., Jones, H., Thijssen, D., Cable, N. T., & Atkinson, G. (2011) · Hypertension · doi:10.1161/hypertensionaha.110.167015 · Cited by 557
Improved analysis of brachial artery ultrasound using a novel edge-detection software system
Woodman, R. J., Playford, D. A., Watts, G. F., Cheetham, C., Reed, C., Taylor, R. R., Puddey, I. B., Beilin, L. J., Burke, V., Mori, T. A., et al. (2001) · Journal of Applied Physiology · doi:10.1152/jappl.2001.91.2.929 · Cited by 533
Maiorana, A., O’Driscoll, G., Cheetham, C., Dembo, L., Stanton, K., Goodman, C., Taylor, R., & Green, D. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01439-5 · Cited by 488
Hyperhomocyst(e)inemia Is a Risk Factor for Arterial Endothelial Dysfunction in Humans
Woo, K. S., Chook, P., Lolin, Y. I., Cheung, A. S. P., Chan, L. T., Sun, Y. Y., Sanderson, J. E., Metreweli, C., & Celermajer, D. S. (1997) · Circulation · doi:10.1161/01.cir.96.8.2542 · Cited by 486
Pritchard, K. A., Groszek, L., Smalley, D. M., Sessa, W. C., Wu, M., Villalon, P., Wolin, M. S., & Stemerman, M. B. (1995) · Circulation Research · doi:10.1161/01.res.77.3.510 · Cited by 471
Heinecke, J. W. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)00173-7 · Cited by 466
Leeuwenburgh, C., Hardy, M. M., Hazen, S. L., Wagner, P., Oh-ishi, S., Steinbrecher, U. P., & Heinecke, J. W. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.3.1433 · Cited by 462
Exercise training enhances endothelial function in young men
Clarkson, P., Montgomery, H. E., Mullen, M. J., Donald, A. E., Powe, A. J., Bull, T., Jubb, M., World, M., & Deanfield, J. E. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00036-4 · Cited by 458
Oral L-arginine improves endothelium-dependent dilation in hypercholesterolemic young adults.
Clarkson, P., Adams, M. R., Powe, A. J., Donald, A. E., McCredie, R., Robinson, J., McCarthy, S. N., Keech, A., Celermajer, D. S., & Deanfield, J. E. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118632 · Cited by 412
Carr, A. C., McCall, M. R., & Frei, B. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.7.1716 · Cited by 386
Kielstein, J. T., Bo[Combining Diaeresis]ger, R. H., Bode-Bo[Combining Diaeresis]ger, S. M., Fro[Combining Diaeresis]lich, J. D. C., Haller, H., Ritz, E., & Fliser, D. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v131170 · Cited by 369
The Determinants of Endothelial Dysfunction in CKD: Oxidative Stress and Asymmetric Dimethylarginine
Yilmaz, M. I., Saglam, M., Caglar, K., Cakir, E., Sonmez, A., Ozgurtas, T., Aydin, A., Eyileten, T., Ozcan, O., Acikel, C., et al. (2006) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.09.029 · Cited by 331
Shimasaki, Y., Yasue, H., Yoshimura, M., Nakayama, M., Kugiyama, K., Ogawa, H., Harada, E., Masuda, T., Koyama, W., Saito, Y., et al. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00167-3 · Cited by 305
Folic acid improves arterial endothelial function in adults with hyperhomocystinemia
Woo, K. S., Chook, P., Lolin, Y. I., Sanderson, J. E., Metreweli, C., & Celermajer, D. S. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00469-6 · Cited by 303
The role of nitric oxide and other endothelium-derived vasoactive substances in vascular disease
Cohen, R. A. (1995) · Progress in Cardiovascular Diseases · doi:10.1016/s0033-0620(05)80002-7 · Cited by 286
Nitric oxide and the proliferation of vascular smooth muscle cells
Jeremy, J. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00171-6 · Cited by 285
Endothelial Dysfunction Late After Kawasaki Disease
Dhillon, R., Clarkson, P., Donald, A. E., Powe, A. J., Nash, M., Novelli, V., Dillon, M. J., & Deanfield, J. E. (1996) · Circulation · doi:10.1161/01.cir.94.9.2103 · Cited by 260
Endothelial nitric oxide (NO) and its pathophysiologic regulation
Chatterjee, A., & Catravas, J. D. (2008) · Vascular Pharmacology · doi:10.1016/j.vph.2008.06.008 · Cited by 236
Transfer of low density lipoprotein into the arterial wall and risk of atherosclerosis
Nielsen, L. B. (1996) · Atherosclerosis · doi:10.1016/0021-9150(96)05802-9 · Cited by 186
Kirk, E. A., Dinauer, M. C., Rosen, H., Chait, A., Heinecke, J. W., & LeBoeuf, R. C. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.6.1529 · Cited by 171
Potential Ergogenic Effects of Arginine and Creatine Supplementation
Paddon-Jones, D., Børsheim, E., & Wolfe, R. R. (2004) · The Journal of Nutrition · doi:10.1093/jn/134.10.2888s · Cited by 119
Endothelial dysfunction and arterial abnormalities in childhood obesity
Skilton, M. R., & Celermajer, D. S. (2006) · International Journal of Obesity · doi:10.1038/sj.ijo.0803397 · Cited by 66
LDL particle size: an important drug target?
Rajman, I., Eacho, P. I., Chowienczyk, P. J., & Ritter, J. M. (1999) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1999.00991.x · Cited by 51
Metadata
- Authors
- Cooke, J. P., & Tsao, P. S.
- Venue
- Arteriosclerosis and Thrombosis: A Journal of Vascular Biology
- Published
- 1994-05
- Volume
- 14
- Issue
- 5
- Pages
- 653-655
- ISSN
- 1049-8834 (ISSN-L)
- OpenAlex
- W2312577844
- Cited by
- 216
- References
- 4
- FWCI
- 8.33
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.